Perspective Therapeutics
CATX
25 hedge funds and large institutions have $2.92M invested in Perspective Therapeutics in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 4 closing their positions.
0.04% less ownership
Funds ownership: 0.78% → 0.74% (-0.04%)
7% less funds holding
Funds holding: 27 → 25 (-2)
21% less capital invested
Capital invested by funds: $3.71M → $2.92M (-$796K)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$18.6K |
| 2 |
Wolverine Trading
Chicago,
Illinois
|
+$8.69K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$449 |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$381 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$70.4K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$43K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$36.1K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$25K |
| 5 |
Bank of New York Mellon
New York
|
-$10.5K |
CATX Hedge Fund Activity: Q3 2016 in Review
25 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q3 2016, worth a combined $2.92M — down 21% from $3.71M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CATX and 2 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 2 added.
The largest buyer was UBS Group, adding an estimated $18.6K. The largest seller was BlackRock Fund Advisors, cutting an estimated $70.4K.
- 25 institutional investors held Perspective Therapeutics (CATX) as of Q3 2016, down from 27 in Q2 2016.
- Funds reported $2.92M of Perspective Therapeutics stock for Q3 2016, down 21% quarter-over-quarter.
- 2 funds opened new Perspective Therapeutics positions in Q3 2016 and 4 closed out, a net change of -2 holders.
- The largest Perspective Therapeutics buyer in Q3 2016 was UBS Group, an estimated $18.6K added.
- The largest Perspective Therapeutics seller in Q3 2016 was BlackRock Fund Advisors, an estimated $70.4K sold.
Based on aggregated 13F filings for Q3 2016.